CARA
Price
$0.75
Change
-$0.06 (-7.41%)
Updated
May 17, 6:59 PM EST
78 days until earnings call
GPCR
Price
$36.15
Change
+$0.27 (+0.75%)
Updated
May 17, 6:59 PM EST
81 days until earnings call
Ad is loading...

CARA vs GPCR

Header iconCARA vs GPCR Comparison
Open Charts CARA vs GPCRBanner chart's image
Cara Therapeutics
Price$0.75
Change-$0.06 (-7.41%)
Volume$161.48K
CapitalizationN/A
Structure Therapeutics
Price$36.15
Change+$0.27 (+0.75%)
Volume$311.55K
CapitalizationN/A
View a ticker or compare two or three
CARA vs GPCR Comparison Chart

Loading...

CARADaily Signal changed days agoGain/Loss if shorted
 
Show more...
GPCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CARA vs. GPCR commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARA is a Hold and GPCR is a Hold.

COMPARISON
Comparison
May 19, 2024
Stock price -- (CARA: $0.75 vs. GPCR: $36.15)
Brand notoriety: CARA and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARA: 69% vs. GPCR: 80%
Market capitalization -- CARA: $41.01M vs. GPCR: $1.69B
CARA [@Biotechnology] is valued at $41.01M. GPCR’s [@Biotechnology] market capitalization is $1.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARA’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 0 green FA rating(s).

  • CARA’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 0 green, 5 red.
According to our system of comparison, GPCR is a better buy in the long-term than CARA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARA’s TA Score shows that 4 TA indicator(s) are bullish while GPCR’s TA Score has 3 bullish TA indicator(s).

  • CARA’s TA Score: 4 bullish, 4 bearish.
  • GPCR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CARA is a better buy in the short-term than GPCR.

Price Growth

CARA (@Biotechnology) experienced а +4.82% price change this week, while GPCR (@Biotechnology) price change was +0.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

CARA is expected to report earnings on Aug 05, 2024.

GPCR is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CARA with price predictions.
OPEN
A.I.dvisor published
a Summary for GPCR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
GPCR($1.69B) has a higher market cap than CARA($41M). CARA YTD gains are higher at: 0.956 vs. GPCR (-11.310).
CARAGPCRCARA / GPCR
Capitalization41M1.69B2%
EBITDAN/AN/A-
Gain YTD0.956-11.310-8%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CARA: Fundamental Ratings
CARA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CARAGPCR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 14 days ago
89%
Declines
ODDS (%)
Bearish Trend 19 days ago
80%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
69%
N/A
View a ticker or compare two or three
Ad is loading...
CARADaily Signal changed days agoGain/Loss if shorted
 
Show more...
GPCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VAAGX27.460.05
+0.18%
Virtus NFJ Large-Cap Value R6
KLGBX39.040.05
+0.13%
MainStay WMC Growth B
VMGIX91.900.11
+0.12%
Vanguard Mid-Cap Growth Index Investor
CGVVX15.02N/A
N/A
Causeway Global Value Inv
MMUGX22.23-0.06
-0.27%
MFS Utilities R1

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with CKPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then CKPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+0.75%
CKPT - GPCR
45%
Loosely correlated
+5.62%
CARA - GPCR
38%
Loosely correlated
-6.84%
MIRM - GPCR
30%
Poorly correlated
-2.75%
MLTX - GPCR
25%
Poorly correlated
-2.72%
MNKD - GPCR
25%
Poorly correlated
N/A
More